Drug Trial Radar · NCT07870239
Comparison of Topical Antibiotics Versus Systemic Antibiotics in Preventing Burn Wound Infection in Pediatric Burn Patients
Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
222
Planned (sponsor's estimate)
Start
Nov 5, 2026
Primary completion
May 5, 2027
Study completion May 5, 2027
Sponsor
- Lead sponsor
- abdul mateenAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 13, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 5 years, up to 13 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Burn wound infection is a common complication in children with burns and can delay healing and increase the risk of complications. This randomized controlled trial will compare two antibiotic strategies for preventing infection in pediatric burn patients. One group will receive topical antibiotics alone, while the other group will receive topical antibiotics along with systemic antibiotics. The study will compare the occurrence of burn wound infection between the two groups to determine whether adding systemic antibiotics provides additional benefit in preventing infection.
Conditions
- Burn
Interventions
Silver Sulfadiazine Cream 1%Drug
Silver sulfadiazine 1% cream applied once daily to the burn wound according to the departmental protocol
Amoxicillin and clavulanateDrug
Amoxicillin plus clavulanate at a total dose of 50 mg/kg/day, administered three times daily according to the departmental protocol.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of burn wound infectionTime frame: From initiation of treatment through the 14-day follow-up visit
Locations
1 site in 1 country. Site status is shown where the registry gives one.
King Edward Medical University
Lahore, Punjab Province, Pakistan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.